imatinib

Imatinib is currently the most popular therapy for chronic myeloid leukemia ( CML ).

伊马替尼是目前治疗慢性髓细胞 白血病 的最普遍药物.

Examples of blood cancer drugs that are taken by mouth are thalidomide, lenalidomide and imatinib mesylate.

治疗血癌的一些口服药物的例子是沙利度胺 、 来那度胺、伊马替尼.

When they tried Gleevec, known generically as imatinib, it had little effect on the cells.

当他们尝试着格列卫，通常被称依马替尼，它很少对细胞有作用。

Background Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib.

有研究表明与伊马替尼相比，尼罗替尼是一种更强效的BCR-ABL抑制剂。

Consider using adjuvant imatinib for at least 3 (rather than 1) years in high-risk patients after resection of GIST.

考虑对手术切除后的GIST高危患者应用辅助伊马替尼治疗至少3年（而不是1年）。